Literature DB >> 25572617

Curbing the tobacco epidemic: Employing behavioral strategies or rearranging the deckchairs on the Titanic?

Alain Braillon1.   

Abstract

Henningfield brilliantly dissected the deadly comprehensive tactics of the tobacco industry but Food and Drug Administration and WHO strategies against the tobacco epidemic must be questioned. The Food and Drug Administration has the authority to regulate tobacco production (2009 Tobacco Control Act) but fails to ban menthol and reduce cigarettes nicotine content. As little has changed, the Healthy People 2010 objective of reducing the prevalence of cigarette smoking among adults to 12% by 2010 in the US will be attained by 2030. The monitoring of the WHO Framework Convention on Tobacco Control (WHO FCTC) is passive, even when governments repeatedly violate the Article 5.3 of the Convention, which specifically requires protecting public policy from tobacco industry interference. Since 2004, the year after the adoption of the Convention, the prevalence of daily smoking has leveled off and the 2012 annualized rate of change in prevalence of daily smoking was almost null. This contrasts with a 2% annual decrease in the prevalence of daily smoking from 1980 to 2004. The tobacco endgame needs acts, not bureaucracies. Two counties have been moving forward, Brazil has banned menthol and Australia has implemented plain packaging.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Control; Food and Drug Administration; Framework Convention on Tobacco; Tobacco endgame

Mesh:

Year:  2015        PMID: 25572617     DOI: 10.1016/j.ypmed.2014.12.026

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  1 in total

1.  Economic evaluation of an exercise-counselling intervention to enhance smoking cessation outcomes: The Fit2Quit trial.

Authors:  William Leung; Vaughan Roberts; Louisa G Gordon; Christopher Bullen; Hayden McRobbie; Harry Prapavessis; Yannan Jiang; Ralph Maddison
Journal:  Tob Induc Dis       Date:  2017-03-29       Impact factor: 2.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.